WO2023248151 - METHOD OF TREATING SKIN FIELD CANCERIZATION WITH ACTINIC KERATOSES
National phase entry is expected:
Publication Number
WO/2023/248151
Publication Date
28.12.2023
International Application No.
PCT/IB2023/056412
International Filing Date
21.06.2023
Title **
[English]
METHOD OF TREATING SKIN FIELD CANCERIZATION WITH ACTINIC KERATOSES
[French]
PROCÉDÉ DE TRAITEMENT DE LA CANCÉRISATION DU CHAMP CUTANÉ AVEC DES KÉRATOSES ACTINIQUES
Applicants **
PYRAMID BIOSCIENCES, INC.
Inventors
PAL, Kollol
PATEL, Girish
THERRIEN, Jean-Philippe
Priority Data
63/355,543
24.06.2022
US
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
EPO
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| 译文 |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 2419 | |
| EPO | Filing, Examination, Granting | 11202 | |
| Japan | Filing, Examination, Granting | 2343 | |
| South Korea | Filing, Examination, Granting | 2405 | |
| USA | Filing, Examination, Granting | 4740 |
Total:
23,109
The term for entry into the National Phase has expired. This quotation is for informational purposes only
Contact Us
Abstract[English]
The present disclosure relates to a method of treating skin field cancerization with actinic keratoses using N-[(1 S)-1-(5-fluoropyrimidin-2-yl)ethyl]-3-(5-isopropoxy-1H-pyrazol-3-yl)-3H-imidazo[4,5-b]pyridin-5-amine (hereinafter also referred to as "Compound A"), or a pharmaceutically acceptable salt thereof.[French]
La présente invention concerne un procédé de traitement de la cancérisation du champ cutané avec des kératoses actiniques à l'aide de N-[(1s)-1-(5-fluoropyrimidin-2-yl)éthyl]-3-(5-isopropoxy-1H-pyrazol-3-yl)-3H-imidazo[4,5-b]pyridin-5-amine (ci-après également appelé "composé A"), ou d'un sel pharmaceutiquement acceptable de celui-ci.